Literature DB >> 16022066

Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report.

Louis S Matza1, Kristina Secnik, Anne M Rentz, Sally Mannix, F Randy Sallee, Donald Gilbert, Dennis A Revicki.   

Abstract

This study used standard gamble (SG) utility interviews to assess parent preferences for health states of childhood attention-deficit/hyperactivity disorder (ADHD). Health state utilities are needed to calculate quality-adjusted life years (QALYs), a critical outcome measure in cost-effectiveness studies of new treatments. Parents (n = 43) of children diagnosed with ADHD completed SG utility interviews, rating their child's current health and 11 hypothetical health states describing untreated ADHD and ADHD treated with a stimulant or non-stimulant. Parents completed questionnaires on their children's symptoms and health-related quality of life (HRQL). Parents' SG rating of their child's current health state (mean of 0.74 on a utility scale ranging from 0 to 1) was significantly correlated with inattentive, hyperactive, and overall ADHD symptoms (r = 0.37, 0.36, and 0.40 respectively; p < 0.05) and psychosocial HRQL domains. Hypothetical health state utilities ranged from 0.48 (severe untreated ADHD) to 0.88 (effective and tolerable non-stimulant treatment). Comparisons between health states found expected differences between untreated mild, moderate, and severe ADHD health states. When both treatments were effective and tolerable, parents preferred the non-stimulant health state over the stimulant health state (p < 0.03). Results suggest that parent SG interviews are a feasible and useful method for obtaining utility scores that can be used in cost-effectiveness models of ADHD treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16022066     DOI: 10.1007/pl00022070

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  31 in total

1.  Recommendations for evaluating the validity of quality of life claims for labeling and promotion.

Authors:  N K Leidy; D A Revicki; B Genesté
Journal:  Value Health       Date:  1999 Mar-Apr       Impact factor: 5.725

2.  Stability of maternal preferences for pediatric health states in the perinatal period and 1 year later.

Authors:  Saroj Saigal; Barbara L Stoskopf; Elizabeth Burrows; David L Streiner; Peter L Rosenbaum
Journal:  Arch Pediatr Adolesc Med       Date:  2003-03

3.  A cost utility analysis of treatment options for gallstone disease: methodological issues and results.

Authors:  J Cook; J Richardson; A Street
Journal:  Health Econ       Date:  1994 May-Jun       Impact factor: 3.046

4.  The standard gamble method: what is being measured and how it is interpreted.

Authors:  A Gafni
Journal:  Health Serv Res       Date:  1994-06       Impact factor: 3.402

5.  The Child Health Questionnaire in Australia: reliability, validity and population means.

Authors:  E Waters; L Salmon; M Wake; K Hesketh; M Wright
Journal:  Aust N Z J Public Health       Date:  2000-04       Impact factor: 2.939

6.  Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications.

Authors:  D A Revicki; M Wood
Journal:  J Affect Disord       Date:  1998-02       Impact factor: 4.839

7.  Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool.

Authors:  Jeanne M Landgraf; Michael Rich; Leonard Rappaport
Journal:  Arch Pediatr Adolesc Med       Date:  2002-04

8.  Comparison of the rating scale and the standard gamble in measuring patient preferences for outcomes of gallstone disease.

Authors:  E B Bass; E P Steinberg; H A Pitt; R I Griffiths; K D Lillemoe; G P Saba; C Johns
Journal:  Med Decis Making       Date:  1994 Oct-Dec       Impact factor: 2.583

9.  Adolescents with ADHD: patterns of behavioral adjustment, academic functioning, and treatment utilization.

Authors:  R A Barkley; A D Anastopoulos; D C Guevremont; K E Fletcher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1991-09       Impact factor: 8.829

10.  Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria.

Authors:  R A Barkley; G J DuPaul; M B McMurray
Journal:  J Consult Clin Psychol       Date:  1990-12
View more
  23 in total

1.  Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy.

Authors:  Damien C Weber; Carmen Ares; Robert Malyapa; Francesca Albertini; Gabriele Calaminus; Ulrike Kliebsch; Lorentzos Mikroutsikos; Petra Morach; Alessandra Bolsi; Tony Lomax; Ralf Schneider
Journal:  J Neurooncol       Date:  2014-11-02       Impact factor: 4.130

Review 2.  Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.

Authors:  Nicole K Schatz; Gregory A Fabiano; Charles E Cunningham; Susan dosReis; Daniel A Waschbusch; Stephanie Jerome; Kellina Lupas; Karen L Morris
Journal:  Patient       Date:  2015-12       Impact factor: 3.883

3.  Variations in Physician Attitudes Regarding ADHD and Their Association With Prescribing Practices.

Authors:  R Christopher Sheldrick; Laurel K Leslie; Angie Mae Rodday; Susan K Parsons; Tully S Saunders; John B Wong
Journal:  J Atten Disord       Date:  2012-11-09       Impact factor: 3.256

Review 4.  The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review.

Authors:  David Coghill
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

5.  Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Authors:  Kristina S Boye; Louis S Matza; Kimberly N Walter; Kate Van Brunt; Andrew C Palsgrove; Aodan Tynan
Journal:  Eur J Health Econ       Date:  2010-03-12

6.  Examining Parents' Preferences for Group and Individual Parent Training for Children with ADHD Symptoms.

Authors:  Frances A Wymbs; Charles E Cunningham; Yvonne Chen; Heather M Rimas; Ken Deal; Daniel A Waschbusch; William E Pelham
Journal:  J Clin Child Adolesc Psychol       Date:  2015-02-20

7.  A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD.

Authors:  Daniel A Waschbusch; Charles E Cunningham; William E Pelham; Heather L Rimas; Andrew R Greiner; Elizabeth M Gnagy; James Waxmonsky; Gregory A Fabiano; Jessica A Robb; Lisa Burrows-Maclean; Mindy Scime; Martin T Hoffman
Journal:  J Clin Child Adolesc Psychol       Date:  2011

8.  Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis.

Authors:  Susan dosReis; Alex Park; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; Ellen M Janssen; John F P Bridges
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-12-19       Impact factor: 2.576

9.  Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations.

Authors:  Andrew Lloyd; Paul Hodgkins; Rahul Sasane; Ron Akehurst; Edmund J S Sonuga-Barke; Patrick Fitzgerald; Annabel Nixon; Haim Erder; John Brazier
Journal:  Patient       Date:  2011       Impact factor: 3.883

10.  Utilities and disutilities for type 2 diabetes treatment-related attributes.

Authors:  Louis S Matza; Kristina S Boye; Nicole Yurgin; Jessica Brewster-Jordan; Sally Mannix; Jodi M Shorr; Beth L Barber
Journal:  Qual Life Res       Date:  2007-07-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.